Beaufour Ipsen is a pharmaceutical company that develops and markets innovative drugs for specialty care. The company focuses on therapeutic areas such as oncology, neuroscience, and rare diseases. Beaufour Ipsen is committed to improving the lives of patients through research and development of advanced medical treatments.
In 1921, Beaufour Ipsen was founded in Paris, France.
The company initially specialized in the production of mineral water and fortified wines.
In the 1950s, Beaufour Ipsen entered the pharmaceutical industry and began developing innovative drugs.
During the 1980s and 1990s, the company expanded its operations globally and entered into strategic partnerships.
In 2001, Beaufour Ipsen merged with the Danish company, Nordisk Gentofte, forming Ipsen.
In recent years, Beaufour Ipsen has focused on the development of biotechnological products and continued expansion into international markets.
Sanofi is a multinational pharmaceutical company based in France. It specializes in research, development, and marketing of prescription drugs, vaccines, and consumer healthcare products.
Novartis is a Swiss multinational pharmaceutical company. It focuses on the research, development, and manufacturing of a wide range of healthcare products, including prescription drugs, generic drugs, and ophthalmic products.
Roche is a Swiss multinational healthcare company. It operates in the fields of pharmaceuticals and diagnostics, with a focus on oncology, immunology, and neurology.
Somatuline is a medication used for the treatment of acromegaly and neuroendocrine tumors. It helps regulate the production of growth hormone and improves symptoms associated with these conditions.
Increlex is a prescription medication used for the treatment of growth failure in children with severe primary IGF-1 deficiency. It helps stimulate growth and development in affected children.
Smecta is an oral powder used to treat acute diarrhea and chronic diarrhea in adults and children. It helps restore normal bowel movements and alleviate symptoms of diarrhea.
Beaufour Ipsen specializes in therapeutic areas such as oncology, neuroscience, and rare diseases.
Beaufour Ipsen is headquartered in Paris, France.
Some of Beaufour Ipsen's main products include Somatuline for acromegaly and neuroendocrine tumors, Increlex for growth failure in children, and Smecta for diarrhea.
Yes, Beaufour Ipsen has expanded its operations globally and is present in various international markets.
Beaufour Ipsen is committed to improving the lives of patients through research and development of advanced medical treatments.